Lawson VA - Search Results

1

Early existence and biochemical evolution characterise acutely synaptotoxic PrPSc.

Foliaki ST, Lewis V, Islam AMT, Ellett LJ, Senesi M, Finkelstein DI, Roberts B, Lawson VA, Adlard PA, Collins SJ. Foliaki ST, et al. Among authors: lawson va. PLoS Pathog. 2019 Apr 10;15(4):e1007712. doi: 10.1371/journal.ppat.1007712. eCollection 2019 Apr. PLoS Pathog. 2019. PMID: 30970042 Free PMC article.

2

Prion acute synaptotoxicity is largely driven by protease-resistant PrPSc species.

Foliaki ST, Lewis V, Finkelstein DI, Lawson V, Coleman HA, Senesi M, Islam AMT, Chen F, Sarros S, Roberts B, Adlard PA, Collins SJ. Foliaki ST, et al. PLoS Pathog. 2018 Aug 8;14(8):e1007214. doi: 10.1371/journal.ppat.1007214. eCollection 2018 Aug. PLoS Pathog. 2018. PMID: 30089152 Free PMC article.

3

PrPSc Oligomerization Appears Dynamic, Quickly Engendering Inherent M1000 Acute Synaptotoxicity.

Foliaki ST, Lewis V, Islam AMT, Senesi M, Finkelstein DI, Ellett LJ, Lawson VA, Adlard PA, Roberts BR, Collins SJ. Foliaki ST, et al. Among authors: lawson va. Biophys J. 2020 Jul 7;119(1):128-141. doi: 10.1016/j.bpj.2020.04.040. Epub 2020 Jun 10. Biophys J. 2020. PMID: 32562618 Free PMC article.

4

Prion protein glycosylation.

Lawson VA, Collins SJ, Masters CL, Hill AF. Lawson VA, et al. J Neurochem. 2005 May;93(4):793-801. doi: 10.1111/j.1471-4159.2005.03104.x. J Neurochem. 2005. PMID: 15857383 Free article. Review.

5

Extended period of asymptomatic prion disease after low dose inoculation: assessment of detection methods and implications for infection control.

Collins SJ, Lewis V, Brazier MW, Hill AF, Lawson VA, Klug GM, Masters CL. Collins SJ, et al. Among authors: lawson va. Neurobiol Dis. 2005 Nov;20(2):336-46. doi: 10.1016/j.nbd.2005.03.014. Neurobiol Dis. 2005. PMID: 16242640

6

Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease.

Brazier MW, Lewis V, Ciccotosto GD, Klug GM, Lawson VA, Cappai R, Ironside JW, Masters CL, Hill AF, White AR, Collins S. Brazier MW, et al. Among authors: lawson va. Brain Res Bull. 2006 Jan 30;68(5):346-54. doi: 10.1016/j.brainresbull.2005.09.010. Epub 2005 Oct 5. Brain Res Bull. 2006. PMID: 16377442

7

Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infection.

Lewis V, Hill AF, Haigh CL, Klug GM, Masters CL, Lawson VA, Collins SJ. Lewis V, et al. Among authors: lawson va. J Neuropathol Exp Neurol. 2009 Oct;68(10):1125-35. doi: 10.1097/NEN.0b013e3181b96981. J Neuropathol Exp Neurol. 2009. PMID: 19918124

8

Acute exposure to prion infection induces transient oxidative stress progressing to be cumulatively deleterious with chronic propagation in vitro.

Haigh CL, McGlade AR, Lewis V, Masters CL, Lawson VA, Collins SJ. Haigh CL, et al. Among authors: lawson va. Free Radic Biol Med. 2011 Aug 1;51(3):594-608. doi: 10.1016/j.freeradbiomed.2011.03.035. Epub 2011 Apr 3. Free Radic Biol Med. 2011. PMID: 21466851

9

Prion subcellular fractionation reveals infectivity spectrum, with a high titre-low PrPres level disparity.

Lewis V, Haigh CL, Masters CL, Hill AF, Lawson VA, Collins SJ. Lewis V, et al. Among authors: lawson va. Mol Neurodegener. 2012 Apr 26;7:18. doi: 10.1186/1750-1326-7-18. Mol Neurodegener. 2012. PMID: 22534096 Free PMC article.

10

Glycosaminoglycan sulfation determines the biochemical properties of prion protein aggregates.

Ellett LJ, Coleman BM, Shambrook MC, Johanssen VA, Collins SJ, Masters CL, Hill AF, Lawson VA. Ellett LJ, et al. Among authors: lawson va. Glycobiology. 2015 Jul;25(7):745-55. doi: 10.1093/glycob/cwv014. Epub 2015 Feb 20. Glycobiology. 2015. PMID: 25701659

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters